Zevra Therapeutics (ZVRA) EBITDA (2014 - 2026)
Zevra Therapeutics' EBITDA was $17.14 million in Q2 2026, compared with -$69.39 million a year earlier and down 67.4% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) EBITDA (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Zevra Therapeutics' EBITDA was $83.87 million through Jun 30, 2026; for FY2025, it came in at -$58.89 million.
- In earlier years, EBITDA was -$80.61 million in FY2024, -$48.6 million in FY2023, -$41.62 million in FY2022 and $7.99 million in FY2021.
- Quarterly EBITDA has moved between -$69.39 million (Q2 2025) and $52.51 million (Q1 2026) over five years.
- Per Business Quant data, ZVRA's EBITDA in the three quarters before Q2 2026 was $52.51 million (Q1 2026), $9.68 million (Q4 2025) and $4.54 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Zevra Therapeutics | 612.56 Mn | -200.15 Mn | 38.18 Mn | 17.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.14 Mn |
| Mar 31, 2026 | 52.51 Mn |
| Dec 31, 2025 | 9.68 Mn |
| Sep 30, 2025 | 4.54 Mn |
| Jun 30, 2025 | -69.39 Mn |
| Mar 31, 2025 | -3.71 Mn |
| Dec 31, 2024 | -13.77 Mn |
| Sep 30, 2024 | -25.69 Mn |
| Jun 30, 2024 | -22.23 Mn |
| Mar 31, 2024 | -18.92 Mn |
| Dec 31, 2023 | -14.37 Mn |
| Sep 30, 2023 | -15.30 Mn |
| Jun 30, 2023 | -6.17 Mn |
| Mar 31, 2023 | -12.75 Mn |
| Dec 31, 2022 | -9.01 Mn |
| Sep 30, 2022 | -6.23 Mn |
| Jun 30, 2022 | -24.59 Mn |
| Mar 31, 2022 | -1.79 Mn |
| Dec 31, 2021 | -2.78 Mn |
| Sep 30, 2021 | -2.16 Mn |
API Access
Zevra Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();